By: ICN Bureau
Last updated : January 27, 2022 5:45 pm
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
Unichem Laboratories Limited has received ANDA approval for its Apremilast Tablets, 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Amgen's Otezla (apremilast) Tablets, 10 mg, 20 mg, and 30 mg.
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.